Explaining the Invisible Using the PEARL System
NCT03025633 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155
Last updated 2019-07-15
Summary
Radiotherapy uses high doses of x-rays directed at tumours to kill them, an unfortunate side effect is healthy surrounding tissue will receive some of the x-ray dose and is damaged. Approximately 22% of radiotherapy patients receive treatment to cure prostate cancer. The technique used requires patients to maintain full bladder and empty bowel because they are next to the prostate, the aim of radiotherapy planning is to minimise the radiation dose received to healthy organs and tissues as this will reduce side effects. PEARL is commercial interactive PC software that shows realistic and functional 3D models of Linac's (machines that deliver radiotherapy treatment). Using PEARL it's possible to display realistic patient treatments including how an individual would be laid on a treatment couch and how the machine will move and sound during treatment. Additionally PEARL provides the opportunity to look inside the body to view internal anatomy and show where the radiotherapy treatment is directed.
Information prior to treatment in radiotherapy is normally given verbally one to one. The investigators believe this information can be more easily understood if PEARL is used in conjunction with this verbal exchange. PEARL gives visual and audio representation of the treatment experience, and demonstrates the reasons behind required preparations.
Research aim is to demonstrate patients who receive information using PEARL have greater understanding, reduced anxiety and reduced radiation dose. This will be tested using two groups of patients receiving radiotherapy to the prostate. Group A - Verbal information, Group B - Verbal information and PEARL demonstration. Data collection is via patient questionnaires and review of Cone Beam Computer Tomography (CBCT) images that are taken prior to each radiotherapy treatment as standard practice. CBCT's are used to locate the treatment area and assess bladder and bowel status and ensure all of these are suitable to deliver treatment accurately.
Conditions
Interventions
- OTHER
-
PEARL
PEARL, is a commercially available PC-based tool that provides a realistic and functional 3D model of a linac and, having uploaded example treatments it can demonstrate the treatment procedure and also relevant anatomical information.
Sponsors & Collaborators
-
Hull University Teaching Hospitals NHS Trust
lead OTHER_GOV
Principal Investigators
-
Victoria A Sykes, BSc (Hons) · Hull University Teaching Hospitals NHS Trust
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-02-28
- Completion
- 2018-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Hypofractionated Online Adaptive Radiotherapy of Breast Cancer
NCT06568705 ·Status: RECRUITING ·Phase: PHASE2
-
Radiotherapy Safety for Liver Malignancies Using Post-Treatment Imaging
NCT07346573 ·Status: COMPLETED
-
MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery
NCT06815289 ·Status: RECRUITING ·Phase: NA
-
Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors
NCT05818462 ·Status: COMPLETED
-
Neoadjuvant Radiotherapy for High-risk UTUC
NCT06472752 ·Status: NOT_YET_RECRUITING
-
Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy
NCT03042156 ·Status: COMPLETED
-
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
NCT00715611 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
PAlliative RAdioTherapy to Lung Cancer A Randomized Multicentre Phase III Study
NCT03632603 ·Status: RECRUITING ·Phase: PHASE3
-
3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors
NCT01470365 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma
NCT06493734 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC
NCT03331575 ·Status: UNKNOWN ·Phase: PHASE3
-
Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer
NCT02031328 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating
NCT00690963 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.
NCT05331833 ·Status: COMPLETED
-
Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction
NCT06362395 ·Status: RECRUITING ·Phase: PHASE3
-
Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial
NCT03077854 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)
NCT01158170 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca
NCT02453737 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
NCT01706432 ·Status: COMPLETED
-
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
NCT03345420 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
NCT02511522 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer
NCT02720614 ·Status: COMPLETED ·Phase: PHASE2
-
Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients
NCT01859650 ·Status: COMPLETED
-
High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
NCT00062335 ·Status: TERMINATED ·Phase: PHASE1